Enzalutamida en este contexto (CPRC): ¿cuáles son los pacientes? - page 40

Genomic alterations in cell-free DNA and enzalutamide

resistance

Wyatt AW, et al. JAMA Oncology 2016

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,30,31,32,33,34,35,36,37,38,39 41,42